A number of detrimental health effects than health benefits in avoiding foods that contain gluten
Coeliac disease affects nearly one percent of the population. In patients with coeliac disease, gluten can cause a gut reaction and prevents the absorption of nutrients. The following are symptoms of the gut reaction.
A survey shows more than 30 percent of the citizens of the United States are trying to avoid foods that contain gluten.
An analytical study conducted by experts in the field of nutrition and medicine shows more detrimental health outcomes than benefits in normal people when they avoid the consumption of gluten free diet. People are consuming foods that contain no gluten and thinking that they are healthy foods.
The scientists say that gluten-free diets should not be suggested to healthy individuals to prevent the future risk of heart diseases.
The researchers came to the above conclusion after analyzing the diet questionnaire of more than 100,000 individuals with no risk of coronary heart disease. The study was published in the British Medical Journal (BMJ).
Gluten: Gluten is a protein found in the most popular whole grains such as rye, wheat, spelt and barley. Gluten causes no harm to most of the people. It causes problems for people with celiac disease (an autoimmune disorder) and to those people who are sensitive to gluten protein.
Some gluten-free grains are rice, corn, flax, millets, oats, quinoa etc. Other foods are fish, dairy, vegetables, eggs, fruits, meat and nuts.
The United States FDA say that gluten is safe to consume.
Overactive Bladder Drugs (OAB) are Associated With the Increased risk of Dementia In Patients with Diabetes
A study by the China Medical University Hospital shows a risk of dementia in patients with diabetes with the long-term use of anticholinergic drugs (drugs such as solifenacin, oxybutynin and tolterodine) for the treatment of overactive bladder (OAB).
The urinary frequency and the urgency to urinate are the characteristics of overactive bladder (OAB).
Anticholinergics are being used for the treatment of overactive bladder. But, these drugs also act on receptors in the brain.
The researchers have conducted a cohort study on a group of 10,938 patients with diabetes who are taking anticholinergic medications and another group of 564,733 patients who are not taking anticholinergic medications. They used the Taiwan National Health Insurance Research Database in the study. The following are the estimates for 6-year dementia.
After matching, the 6-year dementia event rates have decreased in both oxybutynin group (from 3.9 percent to 3.0 percent) and in solifenacin group (from 4.3 percent to 3.5 percent). But it was increased in the control group from 1.2 percent to 2.4 percent.
This study shows a risk of dementia among patients with diabetes who are taking drugs such as solifenacin, oxybutynin and tolterodine.
The author of the study was Yu-Wan Yang from China Medical University Hospital, Taichung, Taiwan and the study was published in the journal PLoS One.
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. The published article is not a medical advice by the OWNER of the "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.